Position in PLRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$125,712
-$22,829 QoQ
Shares Held
99,773
-18.1% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 37.53019353933429.ToString("F0")%
Shared 13.686067372936566.ToString("F0")%
None 48.783739087729145.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. PLRX ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in PLRX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,712 | 99,773 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $148,541 | 121,756 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $224,475 | 151,673 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $366,428 | 315,887 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $690,819 | 511,718 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,207,900 | 547,297 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,113,619 | 456,166 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,282,210 | 305,322 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,472,531 | 300,170 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,790,243 | 154,072 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $982,345 | 56,652 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,368,481 | 130,711 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,651,327 | 212,456 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,782,880 | 143,967 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $414,895 | 19,861 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $117,802 | 14,707 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $94,515 | 13,483 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||